Drugs / resveravine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00303238 | Oct 2004 → Dec 2005 | — | Access Business Group | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | resveravine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00303238 ↗ |